Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Google announced new branded queries filters are rolling out gradually within Google Search Console reporting. You can filter your performance reports by branded or non-branded queries and Google can ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...

The Writers Guild of America East is telling its CBS News members that the network assured them that they won’t face discipline if they decline to respond to new editor-in-chief Bari Weiss’ memo to ...

“I hope you are as excited as I am about the prospect of elevating CBS News to its rightful place as No. 1: the most trusted and most consumed news source in the nation,” Weiss wrote. “So, I’m ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

in Oracle a recursive CTE unfortunately cannot be marked with the recursive keyword (despite the ANSI standard) and in Postgres it must be marked with "recursive". In Oracle a CTE is inherently ...